These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 9016898

  • 1. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A.
    Exp Nephrol; 1998 Feb; 6(2):121-31. PubMed ID: 9567218
    [Abstract] [Full Text] [Related]

  • 3. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 4. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 May; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F.
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
    Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G.
    Kidney Int; 1998 Aug; 54(2):353-9. PubMed ID: 9690201
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Aug; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
    Uhlenius N, Miettinen A, Vuolteenaho O, Tikkanen I.
    Kidney Blood Press Res; 2002 Sep; 25(2):71-9. PubMed ID: 12077487
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
    Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D.
    Kidney Int; 1991 Oct; 40(4):734-41. PubMed ID: 1660550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.
    Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G.
    J Am Soc Nephrol; 2003 Jul; 14(7):1816-24. PubMed ID: 12819241
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
    Peters H, Border WA, Noble NA.
    Kidney Int; 2000 Apr; 57(4):1493-501. PubMed ID: 10760085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.